Nuveen Asset Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $910K | Sell |
355,302
-48,226
| -12% | -$123K | ﹤0.01% | 2753 |
|
|
2024
Q3 | $1.5M | Hold |
403,528
| – | – | ﹤0.01% | 2564 |
|
|
2024
Q2 | $2.55M | Sell |
403,528
-102,897
| -20% | -$650K | ﹤0.01% | 2264 |
|
|
2024
Q1 | $2.72M | Sell |
506,425
-16,052
| -3% | -$86.2K | ﹤0.01% | 2259 |
|
|
2023
Q4 | $2.62M | Buy |
522,477
+45,198
| +9% | +$227K | ﹤0.01% | 2289 |
|
|
2023
Q3 | $807K | Buy |
477,279
+47,554
| +11% | +$80.4K | ﹤0.01% | 2658 |
|
|
2023
Q2 | $1.19M | Buy |
429,725
+189,140
| +79% | +$526K | ﹤0.01% | 2576 |
|
|
2023
Q1 | $438K | Sell |
240,585
-8,313
| -3% | -$15.1K | ﹤0.01% | 2839 |
|
|
2022
Q4 | $3.83M | Sell |
248,898
-21,085
| -8% | -$324K | ﹤0.01% | 2069 |
|
|
2022
Q3 | $1.34M | Sell |
269,983
-3,855
| -1% | -$19.2K | ﹤0.01% | 2601 |
|
|
2022
Q2 | $1.02M | Sell |
273,838
-4,882
| -2% | -$18.2K | ﹤0.01% | 2770 |
|
|
2022
Q1 | $1.56M | Sell |
278,720
-169,558
| -38% | -$951K | ﹤0.01% | 2626 |
|
|
2021
Q4 | $2.73M | Buy |
448,278
+181,842
| +68% | +$1.11M | ﹤0.01% | 2408 |
|
|
2021
Q3 | $2.6M | Sell |
266,436
-311,464
| -54% | -$3.03M | ﹤0.01% | 2548 |
|
|
2021
Q2 | $1.73M | Buy |
+577,900
| New | +$1.73M | ﹤0.01% | 2781 |
|
|
2021
Q1 | – | Sell |
-112,537
| Closed | -$1.5M | – | 3307 |
|
|
2020
Q4 | $1.5M | Sell |
112,537
-731
| -0.6% | -$9.74K | ﹤0.01% | 2645 |
|
|
2020
Q3 | $785K | Buy |
113,268
+472
| +0.4% | +$3.27K | ﹤0.01% | 2791 |
|
|
2020
Q2 | $1.39M | Buy |
+112,796
| New | +$1.39M | ﹤0.01% | 2483 |
|